124 related articles for article (PubMed ID: 27592472)
1. Study on breast cancer animal model of tumor-micro vessel variation before and after the chemotherapy by contrast enhanced ultrasound quantitative analysis.
Zhou SC; Le J; Fan YW; Chen M; Chang C
Pak J Pharm Sci; 2016 Jul; 29(4 Suppl):1407-13. PubMed ID: 27592472
[TBL] [Abstract][Full Text] [Related]
2. Can quantitative contrast-enhanced ultrasonography predict cervical tumor response to neoadjuvant chemotherapy?
Peng C; Liu LZ; Zheng W; Xie YJ; Xiong YH; Li AH; Pei XQ
Eur J Radiol; 2016 Nov; 85(11):2111-2118. PubMed ID: 27776666
[TBL] [Abstract][Full Text] [Related]
3. Quantitative Evaluation of Combretastatin A4 Phosphate Early Efficacy in a Tumor Model with Dynamic Contrast-Enhanced Ultrasound.
Zhang P; Chen Y; Liu J; Yang Y; Lv Q; Wang J; Zhang L; Xie M
Ultrasound Med Biol; 2018 Apr; 44(4):840-852. PubMed ID: 29395676
[TBL] [Abstract][Full Text] [Related]
4. Dose-response relationship in cisplatin-treated breast cancer xenografts monitored with dynamic contrast-enhanced ultrasound.
Chen Y; Han F; Cao LH; Li C; Wang JW; Li Q; Zheng W; Guo ZX; Li AH; Zhou JH
BMC Cancer; 2015 Mar; 15():136. PubMed ID: 25884471
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Analysis of Hepatic Microcirculation in Rabbits After Liver Ischemia-Reperfusion Injury Using Contrast-Enhanced Ultrasound.
Li H; Lu J; Zhou X; Pan D; Guo D; Ling H; Yang H; He Y; Chen G
Ultrasound Med Biol; 2017 Oct; 43(10):2469-2476. PubMed ID: 28684184
[TBL] [Abstract][Full Text] [Related]
6. Quantitative parameters of contrast-enhanced ultrasound in breast invasive ductal carcinoma: The correlation with pathological prognostic factors.
Ji CL; Li XL; He YP; Li DD; Gu XG; Xu HX
Clin Hemorheol Microcirc; 2017; 66(4):333-345. PubMed ID: 28387663
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced US quantitatively detects changes of tumor perfusion in a murine breast cancer model during adriamycin chemotherapy.
Wang JW; Cao LH; Han F; Zheng W; Chen Y; Li AH; Zhou JH
Acta Radiol; 2013 Oct; 54(8):882-8. PubMed ID: 23761553
[TBL] [Abstract][Full Text] [Related]
8. Non-invasive quantification of tumor vascular architecture during docetaxel-chemotherapy.
Mahéo K; Chevalier S; Vibet S; Bougnoux P; Richard S; Serrière S; Bleuzen A; Tranquart F; Goupille C
Breast Cancer Res Treat; 2012 Aug; 134(3):1013-25. PubMed ID: 22438047
[TBL] [Abstract][Full Text] [Related]
9. Potential application value of contrast-enhanced ultrasound in neoadjuvant chemotherapy of breast cancer.
Cao X; Xue J; Zhao B
Ultrasound Med Biol; 2012 Dec; 38(12):2065-71. PubMed ID: 23062366
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound (CEUS) in assessing early response among patients with invasive breast cancer undergoing neoadjuvant chemotherapy.
Saracco A; Szabó BK; Tánczos E; Bergh J; Hatschek T
Acta Radiol; 2017 Apr; 58(4):394-402. PubMed ID: 27461224
[TBL] [Abstract][Full Text] [Related]
11. Quantitative contrast-enhanced ultrasound evaluation of pathological complete response in patients with locally advanced breast cancer receiving neoadjuvant chemotherapy.
Wan CF; Liu XS; Wang L; Zhang J; Lu JS; Li FH
Eur J Radiol; 2018 Jun; 103():118-123. PubMed ID: 29803376
[TBL] [Abstract][Full Text] [Related]
12. Assessment of early tumor response to cytotoxic chemotherapy with dynamic contrast-enhanced ultrasound in human breast cancer xenografts.
Wang JW; Zheng W; Liu JB; Chen Y; Cao LH; Luo RZ; Li AH; Zhou JH
PLoS One; 2013; 8(3):e58274. PubMed ID: 23469274
[TBL] [Abstract][Full Text] [Related]
13. Early Response Assessed by Contrast-Enhanced Ultrasound in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.
Dong T
Ultrasound Q; 2018 Jun; 34(2):84-87. PubMed ID: 29420367
[TBL] [Abstract][Full Text] [Related]
14. Early Prediction of Response to Neoadjuvant Chemotherapy Using Quantitative Parameters on Automated Breast Ultrasound Combined with Contrast-Enhanced Ultrasound in Breast Cancer.
Xie Y; Chen Y; Wang Q; Li B; Shang H; Jing H
Ultrasound Med Biol; 2023 Jul; 49(7):1638-1646. PubMed ID: 37100671
[TBL] [Abstract][Full Text] [Related]
15. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
[TBL] [Abstract][Full Text] [Related]
16. Prediction of treatment responses to neoadjuvant chemotherapy in breast cancer using contrast-enhanced ultrasound.
Huang Y; Le J; Miao A; Zhi W; Wang F; Chen Y; Zhou S; Chang C
Gland Surg; 2021 Apr; 10(4):1280-1290. PubMed ID: 33968680
[TBL] [Abstract][Full Text] [Related]
17. A multitargeted, metronomic, and maximum-tolerated dose "chemo-switch" regimen is antiangiogenic, producing objective responses and survival benefit in a mouse model of cancer.
Pietras K; Hanahan D
J Clin Oncol; 2005 Feb; 23(5):939-52. PubMed ID: 15557593
[TBL] [Abstract][Full Text] [Related]
18. The detection of pCR after PST by contrast-enhanced ultrasonography for breast cancer.
Fujisawa T; Hirakata T; Yanagita Y; Iijima M; Horikoshi H; Takeuchi K; Saitoh Y
Breast Cancer; 2013 Jan; 20(1):75-82. PubMed ID: 22203579
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
20. Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.
Merz M; Komljenovic D; Semmler W; Bäuerle T
Invest Radiol; 2012 Jul; 47(7):422-9. PubMed ID: 22659593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
